Markets:

Overview

News

Currencies

International

Treasuries

Cardinal Health (NY:CAH)

221.64 +5.34 (+2.47%)

Streaming Delayed Price Updated: 10:18 AM EDT, Jun 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cardinal Health

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

19 20 Next >

3 Stocks to Buy at 52-Week Lows: March 4 Edition ↗

March 04, 2024

Sometimes a gem can get tossed in the trash, which is what you will find with these three stocks to buy at 52-week lows.

Via InvestorPlace

If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today ↗

February 28, 2024

Via Benzinga

Shake Shack, Cardinal Health And More: CNBC's 'Final Trades' ↗

February 16, 2024

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said she likes Invesco S&P 500 Equal Weight Energy ETF (NYSE:

Via Benzinga

Topics ETFs

Dividend Income Update January 2024 ↗

February 15, 2024

It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio

Via Talk Markets

Cardinal Health Stock Shows Healthy Improvement To Its Technical Strength ↗

February 14, 2024

On Wednesday, Cardinal Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 69 to 78.

Via Investor's Business Daily

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today ↗

February 02, 2024

Via Benzinga

Earnings Preview: Cardinal Health ↗

January 31, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Cardinal Health Stock In The Last 5 Years ↗

January 10, 2024

Via Benzinga

How Is The Market Feeling About Cardinal Health? ↗

January 03, 2024

Via Benzinga

US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation ↗

February 14, 2024

FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices.

Via Benzinga

Why Is Healthcare Services Provider Cardinal Health Stock Trading Lower Today? ↗

February 01, 2024

Cardinal Health reports strong Q2 FY24 results: Adjusted EPS up 38% to $1.82, beating consensus. Q2 revenue for pharmaceutical segment rises 12% to $53.5 billion. Raised FY24 EPS guidance to...

Via Benzinga

Nasdaq Futures Rebound As Traders Eye Apple, Meta, Amazon Earnings: Analyst Flags 'January Barometer' That Bodes Well For The Year ↗

February 01, 2024

After ending January with modest gains, the major averages now look to earnings catalysts to drive momentum, with futures higher in first trading session of February.

Via Benzinga

Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today ↗

January 01, 2024

Via Benzinga

$1000 Invested In Cardinal Health 5 Years Ago Would Be Worth This Much Today ↗

December 11, 2023

Via Benzinga

How Is The Market Feeling About Cardinal Health? ↗

December 04, 2023

Via Benzinga

Earnings Scheduled For February 1, 2024 ↗

February 01, 2024

Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on...

Via Benzinga

Cardinal Health Inc. (NYSE: CAH) Climbs to New 52-Week High

January 31, 2024

Via Investor Brand Network

Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism? ↗

January 29, 2024

An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending.

Via Benzinga

Topics Artificial Intelligence

3 Top-Ranked Large-Caps To Buy For Growth ↗

January 14, 2024

Large-cap stocks are frequently targeted among investors. They typically have greater stability and a proven track record, two reasons why they're beloved.

Via Talk Markets

2023 Year-End Sector Review – Part 2 ↗

January 13, 2024

In this 2023 year-end sector review, we will take a look at what kind of year it was for healthcare, industrial, technology, materials, REITs, and utility sectors. Additionally, how is 2024 shaping up...

Via Talk Markets

Dow Resumes Selloff, Set To Snap Win Streak ↗

January 09, 2024

Stocks have resumed their trek lower in what has become an alarming trend to start 2024.

Via Talk Markets

Topics Stocks

What's Going On With Cardinal Health Shares Today? ↗

January 09, 2024

Cardinal Health Inc (NYSE: CAH) shares are trading lower by around 4% after the company provided an update on its FY24 outlook and ongoing portfolio review.

Via Benzinga

Will My Portfolio’s Top 3 Performing Stocks From 2023 Deliver Again in 2024? ↗

January 01, 2024

This stock expert takes a look at his portfolio's top performing stocks from the last year.

Via InvestorPlace

Best Performing Stocks In January Over The Last Two Decades (75%+ Win Rate) ↗

December 29, 2023

January is generally one of the weakest months of the year for the stock market, but the following stocks have excelled in January over the last 15 years or more.

Via Talk Markets

Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 16 ↗

December 16, 2023

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Dec. 11-15.

Via Talk Markets

10 Health Care Stocks Whale Activity In Today's Session ↗

December 14, 2023

Via Benzinga

3 No-Brainer Stocks to Buy in December ↗

December 07, 2023

These are no-brainer stocks to buy regardless of whether we are in a bull or bear market. Strong tailwinds continue to push them forward.

Via InvestorPlace

Becton Dickinson Recall Certain Infusion Pumps Due To Compatibility Issues With Cardinal Health's Monoject Syringes ↗

December 04, 2023

Friday, the FDA said that Becton, Dicki

Via Benzinga

Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback' ↗

November 29, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would not buy CRISPR Therapeutics AG (NASDAQ: CRSP) stock "all the way up here.

Via Benzinga

Jim Cramer Bullish On Boeing In Latest 'Lightning Round': 'This Is Their Year' ↗

November 28, 2023

Cramer's optimism about Boeing follows his previous praise for the company in April 2023, when he referred to it as "really incredible."

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.